(Q38039381)

27 August 2017

title

What's all the fuss about? facts and figures about bone marrow failure and conditions (English)

1 reference

27 August 2017

Sudipto Mukherjee

1

1 reference

27 August 2017

Mikkael A Sekeres

series ordinal

2

1 reference

27 August 2017

publication date

1 December 2012

1 reference

Current hematologic malignancy reports

27 August 2017

published in

1 reference

27 August 2017

volume

7

1 reference

27 August 2017

issue

4

1 reference

27 August 2017

page(s)

300-309

1 reference

https://scigraph.springernature.com/pub.10.1007/s11899-012-0134-1

27 August 2017

exact match

0 references

cites work

Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs.

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Myelodysplastic syndrome in New Zealand and Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Epidemiological characteristics of myelodysplastic syndrome in a well-defined French population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d'Or (Burgundy, France)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Incidence and prevalence of myelodysplastic syndromes: data from the Düsseldorf MDS-registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Epidemiological and etiological aspects of myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Age and sex distributions of hematological malignancies in the U.K.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Application of different prognostic scoring systems and comparison of the FAB and WHO classifications in Korean patients with myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Predominance of trisomy 1q in myelodysplastic syndromes in Korea: is there an ethnic difference? A 3-year multi-center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Unexplained anemia predominates despite an intensive evaluation in a racially diverse cohort of older adults from a referral anemia clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Anemia in older persons: etiology and evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Estimating the prevalence of myelodysplastic syndromes in patients with unexplained cytopenias: a retrospective study of 322 bone marrows

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Characteristics of US patients with myelodysplastic syndromes: results of six cross-sectional physician surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Myelodysplastic syndromes: 2012 update on diagnosis, risk-stratification, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Daily practice management of myelodysplastic syndromes in France: data from 907 patients in a one-week cross-sectional study by the Groupe Francophone des Myelodysplasies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Diagnosis and therapy of myelodysplastic syndromes in Germany: a retrospective multicenter analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Occupational and environmental risk factors of the myelodysplastic syndromes in the North of France.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Smoking and alcohol intake as risk factors for myelodysplastic syndromes (MDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Risk of myelodysplastic syndromes in people exposed to ionizing radiation: a retrospective cohort study of Nagasaki atomic bomb survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

A novel CBFA2 single-nucleotide mutation in familial platelet disorder with propensity to develop myeloid malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation to age, cumulative dose of alkylating agents, and time from chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Second malignancies in children treated for non-Hodgkin's lymphoma and T-cell leukaemia with the UKCCSG regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Increased incidence of transformation and myelodysplasia/acute leukemia in patients with Waldenström macroglobulinemia treated with nucleoside analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

The Risk of Therapy-Related Myelodysplasia/Acute Myeloid Leukemia in Hodgkin Lymphoma has Substantially Decreased in the ABVD Era Abolishing Mechlorethamine and Procarbazine and Limiting Volumes and Doses of Radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Granulocyte colony-stimulating factor and the risk of secondary myeloid malignancy after etoposide treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Acute myeloid leukemia and myelodysplastic syndromes after radiation therapy are similar to de novo disease and differ from other therapy-related myeloid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Detection of paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes and related bone marrow diseases, with emphasis on diagnostic pitfalls and caveats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Clinical significance of a minor population of paroxysmal nocturnal hemoglobinuria-type cells in bone marrow failure syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Aplastic anaemia incidence in parts of the United Kingdom in 1985

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Aplastic anemia in Brazil: incidence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

The epidemiology of aplastic anemia in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

The epidemiology of acquired aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

A functional single-nucleotide polymorphism of the G-CSF receptor gene predisposes individuals to high-risk myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Acute Myeloid Leukemia Following Hodgkin Lymphoma: A Population-Based Study of 35 511 Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Outcome in Patients With Myelodysplastic Syndrome After Autologous Bone Marrow Transplantation for Non-Hodgkin's Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0134-1

Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow Transplantation

21 January 2018

1 reference

12 December 2020

Clinical characteristics of Japanese patients with primary myelodysplastic syndromes: a co-operative study based on 838 cases. Anemia Study Group of the Ministry of Health and Welfare

1 reference

12 December 2020

Origin and fate of blood cells deficient in glycosylphosphatidylinositol-anchored protein among patients with bone marrow failure

1 reference

12 December 2020

Mutation of CEBPA in familial acute myeloid leukemia

1 reference

12 December 2020

Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies

1 reference

12 December 2020

The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation.

1 reference

12 December 2020

Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories

1 reference

12 December 2020

Myelodysplastic syndromes: incidence and survival in the United States

1 reference

12 December 2020

Risk factors of myelodysplastic syndromes: a case-control study

1 reference

12 December 2020

International workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy-related myelodysplastic syndromes and acute leukemia: overview report

1 reference

12 December 2020

Aplastic anemia: which treatment?

1 reference

12 December 2020

Myelodysplastic syndromes in Thailand: a retrospective pathologic and clinical analysis of 117 cases

1 reference

12 December 2020

Role of MTHFR (677, 1298) haplotype in the risk of developing secondary leukemia after treatment of breast cancer and hematological malignancies

1 reference

12 December 2020

Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma

1 reference

12 December 2020

Incidence of myelodysplastic syndromes in a Swedish population

1 reference

12 December 2020

Epidemiology of aplastic anemia in France: a prospective multicentric study. The French Cooperative Group for Epidemiological Study of Aplastic Anemia.

1 reference

12 December 2020

High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologo

1 reference

12 December 2020

1 reference

12 December 2020

Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors

1 reference

12 December 2020

The incidence and outcome of myeloid malignancies in 2,112 adult patients in southeast England

1 reference

12 December 2020

Incidence survey of aplastic anemia in China

1 reference

12 December 2020

Susceptibility gene for familial acute myeloid leukemia associated with loss of 5q and/or 7q is not localized on the commonly deleted portion of 5q

1 reference

12 December 2020

Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.

1 reference

12 December 2020

Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up

1 reference

12 December 2020

Familial MDS with 5q- abnormality

1 reference

12 December 2020

Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia

1 reference

12 December 2020

Sex ratios and the risks of haematological malignancies

1 reference

12 December 2020

10.1007/S11899-012-0134-1

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1032297112

0 references

1 reference